The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - SynCoreBio
Stock and Other Ownership Interests - SynCoreBio
Speakers' Bureau - SynCoreBio
Research Funding - SynCoreBio
Patents, Royalties, Other Intellectual Property - SynCoreBio (Inst)

EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment (NCT03126435).
 
Li-Tzong Chen
No Relationships to Disclose
 
Muh-Hwan Su
No Relationships to Disclose